Breast Neoplasms: all 12,820 studies
Page 98 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- Breast Reconstruction With Acellular Dermal Matrix in the Setting of Breast Cancer TreatmentCompletedNCT02061527Not applicable
- HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer Post Neoadjuvant ChemotherapyCompletedNCT02061423Phase 1
- DC Vaccine for Patients With Ductal Carcinoma In SituCompletedNCT02061332Phase 1/2
- Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast CancerCompletedNCT02060253Phase 1
- Dose-dense (Biweekly) Carboplatin Plus Paclitaxel With or Without Trastuzumab as Neoadjuvant Treatment for Breast CancerStatus unknownNCT02059876Phase 2
- Quantitative Methods for Supplementing Contrast-Enhanced Magnetic Resonance Imaging of Breast CancerCompletedNCT02058758
- Reirradiation With Concurrent Paclitaxel for Breast CancerWithdrawnNCT02058667Phase 1
- Feasibility Testing and Evaluation of an Online Toolkit for Male Spouses of Women With Breast CancerCompletedNCT02058615Phase 3
- A Phase Ib Dose De-escalation Study With BYL719 in Premenopausal Patients With Locally Advanced or Metastatic Breast CancerCompletedNCT02058381Phase 1
- The Effect of an Exercise Program in Breast Cancer Patients With Joint Pain While Taking Aromatase Inhibitors.CompletedNCT02057536Not applicable
- Image-guided Breast Surgery in the Advanced Multimodality Image Guided Operating Suite (AMIGO)CompletedNCT02057432Not applicable
- A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has SpreadActive, not recruitingNCT02057133Phase 1
- Assessment of the Decision-making Impact of the Breast Cancer Index in Recommending Extended Adjuvant Endocrine Therapy for Patients With Early Stage ER-positive Breast CancerCompletedNCT02057029Not applicable
- Medico-economic Study of Three Strategies of Sentinel Lymph Node Analysis in Operable Breast CancerCompletedNCT02056886Not applicable
- Clinical Benefit of the Treatment With Trastuzumab in Combination With Lapatinib in Metastatic Breast Cancer HER2 Positive Patients Who Has Been Previously Treated With Trastuzumab and/or LapatinibCompletedNCT02056080
- A Phase II Trial Testing Oral Administration of Lucitanib in Patients With Fibroblast Growth Factor Receptor (FGFR)1-amplified or Non-amplified Estrogen Receptor Positive Metastatic Breast CancerCompletedNCT02053636Phase 2
- TRIal evalUating the Menstrual and Ovarian Function of Young Breast Cancer Patients Treated With a cycloPHosphamide-free RegimenWithdrawnNCT02053597Phase 2
- Behavioral Weight Loss and Exercise After Treatment (BEAT)Status unknownNCT02052115Not applicable
- Study to See Whether Breath-Hold Techniques During RT Are Effective in Helping to Improve Sparing of the HeartStatus unknownNCT02052102Phase 2
- A Study to Evaluate the Potential Benefit of the Addition of BYL719 to Paclitaxel in the Treatment of Breast Cancer and Head-and-neck CancerCompletedNCT02051751Phase 1
- Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 WeeksTerminatedNCT02051218Phase 3
- ABC Survey - do we Meet the Needs of Patients With Advanced Breast Cancer?CompletedNCT02051010
- TAILORx Tissue BankActive, not recruitingNCT02050750
- Self-Reported Exercise Behavior and Short-Term Patient Outcomes in Women Undergoing Radiation Treatment for Operable Breast CancerCompletedNCT02050620
- Sentinel Node Biopsy in Breast Cancner: Omission of Axillary Clearance After MicrometastasisCompletedNCT02049632Not applicable
- ANG1005 in Breast Cancer Patients With Recurrent Brain MetastasesCompletedNCT02048059Phase 2
- Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT02046421Phase 1
- Evaluation of Needle Core Biopsy of Axillary Sentinel Lymph Node in Breast CancerCompletedNCT02046057Not applicable
- Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVRCompletedNCT02043184Not applicable
- Automated Breast Ultrasound and Digital Breast Tomosynthesis Screening Compared to Full Field Digital Mammography in Women With Dense BreastsTerminatedNCT02042456
- Biomarkers of Fatigue Related to Adjuvant Chemotherapy for Breast CancerStatus unknownNCT02041364
- Biweekly Docetaxel in Patients With Metastatic Breast Cancer.CompletedNCT02041351Phase 2
- Study of Optimizing Neoadjuvant Regimens in Subtypes of Breast CancerStatus unknownNCT02041338Phase 2
- A Study of SC Administration of Trastuzumab (Herceptin) by SID at Home in HER2-Positive EBC ParticipantsCompletedNCT02040935Phase 3
- Intra-Operative Radiation Therapy Immediately Following Resection of Early Stage Breast CancerTerminatedNCT02040493Not applicable
- LightPathTM Imaging System for Ex-vivo Assessment of Margin and Lymph Node Status in Breast Cancer Surgical SpecimensCompletedNCT02037269
- DETECT IV - A Study in Patients With HER2-negative Metastatic Breast Cancer and Persisting HER2-negative Circulating Tumor Cells (CTCs).CompletedNCT02035813Phase 2
- Prevention of Breast Cancer Recurrence Through Weight Control, Diet, and Physical Activity InterventionStatus unknownNCT02035631Phase 3
- Digital Breast Tomosynthesis Guided Tomographic Optical Breast Imaging (TOBI)Status unknownNCT02033486Not applicable
- Genomic Signatures to Predict Treatment ResponseCompletedNCT02032745
- A Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects With Early Stage Triple Negative Breast CancerCompletedNCT02032277Phase 3
- Sentinel Node Biopsy Before and/or After Neoadjuvant Chemotherapy in Breast CancerCompletedNCT02031042
- A Phase II Study of Irinotecan in 3 Line or More Therapy in Local Recurrence or Metastatic Breast CancerStatus unknownNCT02030678Phase 2
- The Use of Smart Scales for Weight Gain Prevention in African American Breast Cancer SurvivorsCompletedNCT02030353Not applicable
- Evaluation of Response to Two Schedules of Capecitabine in Patients With Metastatic Breast CancerStatus unknownNCT02028494Not applicable
- Pet Imaging as a Biomarker in Hormone Refractory postmenopausaL WomenCompletedNCT02028364Phase 2
- Study of the ICG Distribution in the Margins of Breast Cancer After TumorectomyCompletedNCT02027818Phase 2
- Exemestane Plus Everolimus for Hormone-receptor Positive Metastatic Breast CancerStatus unknownNCT02025712Phase 2
- A Study of Tucatinib (ONT-380) Combined With Capecitabine and/or Trastuzumab in Patients With HER2+ Metastatic Breast CancerCompletedNCT02025192Phase 1
- Evaluation of Magnetic Resonance Imaging (MRI) vs Molecular Breast Imaging (Tc-MBI) in Breast Cancer PatientsTerminatedNCT02024074Phase 1
- Danish Observational Study of Everolimus Plus Exemestane in Hormone Receptor (HR) Positive, Human Epidermal Growth Factor 2 (HER2) - Metastatic Breast CancerCompletedNCT02023359
- Interactive Gentle Yoga in Improving Quality of Life in Patients With Stage I-III Breast Cancer Undergoing Radiation TherapyTerminatedNCT02023008Not applicable
- DCE-MRI and DWI for Detection and Diagnosis of Breast CancerStatus unknownNCT02022579Not applicable
- Phase Ib Trial of Two Folate Binding Protein Peptide Vaccines (E39 and J65) in Breast and Ovarian Cancer PatientsCompletedNCT02019524Phase 1
- Accuracy of FNA Versus CNB of Abnormal Axillary Lymph Nodes in Setting of Invasive Breast CancerCompletedNCT02019303Not applicable
- Increased Frequency of AlloStim(TM) Dosing in Combination With Cryoablation in Metastatic Breast Cancer PatientsWithdrawnNCT02018419Phase 1/2
- Safety of Breast Conserving Treatment in Locally Advanced Breast Cancer Receiving Neoadjuvant TreatmentTerminatedNCT02017496
- Effect of Physical Therapy on Breast Cancer Related LymphedemaCompletedNCT02015897Not applicable
- Mucoadhesive Oral Wound Rinse in Preventing and Treating Stomatitis in Patients With ER- or PR-Positive Metastatic or Locally Recurrent Breast Cancer That Cannot be Removed by Surgery Receiving EverolimusCompletedNCT02015559Phase 2
- Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid TumorsCompletedNCT02014337Phase 1
- MBI and Breast Tomosynthesis Screening Accuracies in Patients With Dense Breast TissueWithdrawnNCT02013726Not applicable
- Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By SurgeryCompletedNCT02013492Early Phase 1
- Metronomic Chemotherapy of Capecitabine After Standard Adjuvant Chemotherapy in Operable Triple Negative Breast CancerStatus unknownNCT02012634
- Standardization Research of TCM Syndrome Differentiation and Treatment on Advanced Breast CancerTemporarily not availableNCT02011880
- Exploring Biological Linkage Between Circadian Disruption and Cancer ProgressionCompletedNCT02011815
- Screening Mammography and Latinas: A Multilevel InterventionCompletedNCT02010008Not applicable
- Evaluation of a Novel Infra-red Breast Imaging System for Risk Assessment in Women at High Risk for Breast Cancer.Status unknownNCT02009150
- Phase II Study Using Genomic & Proteomic Profiling to Influence Treatments for Patients With Metastatic Breast CancerTerminatedNCT02008994Phase 2
- Randomized Phase II Study to Assess PD 0332991 in Breast CancerCompletedNCT02008734Phase 2
- The Accuracy of Sentinel Node Biopsy of Breast Cancer With Sonographic Abnormal Axillary Lymph NodesCompletedNCT02005926Phase 2
- Anesthesia and Circulating Tumor Cells in Breast CancerCompletedNCT02005770Phase 4
- Levobupivacaine and Lidocaine for Paravertebral Block Causes Greater Hemodynamic Oscillations Than LevobupivacaineActive, not recruitingNCT02004834Phase 4
- Randomized Controlled Single-blind Trial to Evaluate the Mobile Tracking of Symptoms in Ambulatory Breast Cancer PatientsTerminatedNCT02004496Not applicable
- Laser InGaAlP (660Nm) to Prevent Radiodermatitis in Breast Cancer Patients Submitted to Radiation TherapyCompletedNCT02003599Not applicable
- Accelerated Partial Breast Irradiation With 3D-CRT and IMRTStatus unknownNCT02003560Phase 2
- RX-5902 Treatment of Subjects With Triple Negative Breast CancerTerminatedNCT02003092Phase 1/2
- Additional 4 Cycles of Cisplatin (CDDP4) in Patients With Triple Negative Breast Cancer for Neoadjuvant ChemotherapyCompletedNCT02001519Phase 2
- Neoadjuvant Chemotherapy of 6 Cycles vs 8 Cycles in Node Positve Breast CancerCompletedNCT02001506Phase 3
- A Phase II Study Evaluating the Role of Androgen Receptors as Targets for Therapy of Pre-treated Post-menopausal Patients With ER/PgR-negative/AR-positive or ER and/or PgRpositive/ AR-positive Metastatic Breast Cancer (ARTT)TerminatedNCT02000375Phase 2
- Maintenance Hormone Therapy for Postmenopausal HR Positive Advanced Breast CancerStatus unknownNCT02000193Phase 2
- Automated Breast Radiation Therapy Using an MR-Guided ProcessCompletedNCT01999062Not applicable
- Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer, TRAIN-2Active, not recruitingNCT01996267Phase 3
- Intraoperative Imagery of Breast Cancer With Folate-FITC (EC17)CompletedNCT01994369Phase 1
- ICG Distribution Using NIF Imaging After IV Injection of ICG in Benign and Malignant Breast Cancer Tissue.CompletedNCT01993576Phase 1/2
- Multiplex Testing for Breast Cancer Susceptibility: A Pilot Study of Subject Preferences for Information and Responses After TestingCompletedNCT01992471
- Brain Functional MRI in Older Women With Breast Cancer (Brain fMRI-BC)Active, not recruitingNCT01992432
- Cryoablation of Small Breast Tumors in Early Stage Breast CancerStatus unknownNCT01992250Not applicable
- H.E.R.O.S. Study: An Observational Study of the Cardiac Safety of Herceptin (Trastuzumab) in Patients With HER2-Positive Breast CancerCompletedNCT01991340
- Bevacizumab Plus Paclitaxel Optimization Study With Interventional Aintenance Endocrine Therapy in Breast CancerCompletedNCT01989780Phase 2
- IORT (Intra-operative Radiation Therapy) in Early Stage Breast CancerCompletedNCT01988870Not applicable
- AR and ER Imaging in Metastatic Breast CancerCompletedNCT01988324Phase 2
- Comprehensive Gene Sequencing in Guiding Treatment Recommendations Patients With Metastatic or Recurrent Solid TumorsCompletedNCT01987726
- Diagnostic Accuracy and Safety Study of FES PET/CT in Assessment of ER Status of Recurrent or Metastatic Breast CancerCompletedNCT01986569Phase 3
- LTX-315 in Patients With Transdermally Accessible Tumours as Monotherapy or Combination With Ipilimumab or PembrolizumabCompletedNCT01986426Phase 1
- Yoga for Breast CancerCompletedNCT01985945Not applicable
- Safety and Efficacy of Lapatinib Plus Trastuzumab or Lapatinib Plus Capecitabine in Metastatic Breast CancerWithdrawnNCT01985893Phase 2
- Bevacizumab in Combination With Chemotherapy in the Neo-adjuvant Setting for HER2 (-) Breast CancerTerminatedNCT01985841Phase 2
- Sequential Administration of FE75C and Docetaxel Versus Docetaxel/Cyclophosphamide in HER-2 Negative, Node Positive Breast CancerCompletedNCT01985724Phase 3
- CPR Prediction After Neoadjuvant Using Excisional Biopsy By Radiofrequency In Breast Cancer From II-III UICC Stages.TerminatedNCT01984866
- REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor TherapyActive, not recruitingNCT01984138Phase 2